COST EFFECTIVENESS OF LENVATINIB, SORAFENIB, AND PLACEBO IN TREATMENT OF RADIOIODINE-REFRACTORY DIFFERENTIATED THYROID CANCER

May 1, 2016, 00:00
10.1016/j.jval.2016.03.1307
https://www.valueinhealthjournal.com/article/S1098-3015(16)01375-9/fulltext
Title : COST EFFECTIVENESS OF LENVATINIB, SORAFENIB, AND PLACEBO IN TREATMENT OF RADIOIODINE-REFRACTORY DIFFERENTIATED THYROID CANCER
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)01375-9&doi=10.1016/j.jval.2016.03.1307
First page : A204
Section Title : Diabetes/Endocrine Disorders - Cost Studies
Open access? : No
Section Order : 647
Categories :
Tags :
Regions :
ViH Article Tags :